Innovative Research Award
Muzaffer Sanci — İzmir Şehir Hastanesi, Turkey
Muzaffer Sanci is a researcher affiliated with İzmir Şehir Hastanesi in Turkey whose documented scholarly profile is associated with epidemiology. The recognition presented here concerns the Innovative Research Award within the Global Diseases Research Awards, emphasizing research activity, publication output, citation visibility, and potential relevance to contemporary disease research.[1]
Abstract
Muzaffer Sanci’s academic profile indicates sustained research activity in epidemiology, supported by 165 indexed documents, 1,526 citations, and an h-index of 21. His affiliation with İzmir Şehir Hastanesi, Turkey, places the profile within a clinical and public-health environment relevant to disease investigation. The Innovative Research Award recognizes research-oriented contributions where methodological development, evidence generation, and practical relevance may support advances in health science. The available bibliometric indicators provide a quantitative description of scholarly visibility, while interpretation of individual contributions should consider publication quality, authorship roles, research methods, and relevance to global disease challenges and population health priorities.[1]
Keywords
Muzaffer Sanci; epidemiology; innovative research; disease research; clinical research; bibliometrics; Scopus; Global Diseases Research Awards; Turkey.[1]
Introduction
Epidemiology examines the distribution, determinants, and control of health-related conditions across populations. Its methods support disease surveillance, risk assessment, prevention, and evaluation of interventions. Researchers working in clinical and population-health settings can contribute evidence that connects observed health patterns with diagnostic, therapeutic, and public-health decision-making and policy development.[2]
Research Profile
The supplied Scopus information records 165 documents, 1,526 citations, and an h-index of 21 for Muzaffer Sanci. These indicators describe indexed publication activity and citation impact, but they do not independently establish research quality. Bibliometric measures should therefore be interpreted alongside study design, originality, collaboration, and substantive contribution to knowledge and practice.[1]
Research Contributions
An epidemiology-focused research profile may encompass investigation of disease patterns, risk factors, clinical outcomes, prevention strategies, and population-level evidence. For award assessment, relevant contributions can be examined through documented publications, methodological approaches, datasets, collaborations, and the extent to which findings address clearly defined scientific or healthcare problems in practice.[2]
Publications
The supplied profile identifies 165 Scopus-indexed documents but does not provide a complete publication list or individual article metadata. Consequently, this article does not attribute specific findings to particular papers without verification. Publication assessment should use the author’s indexed record, including titles, journals, citation counts, authorship position, and persistent identifiers.[1]
Research Impact
A citation count of 1,526 and an h-index of 21 indicate measurable scholarly visibility within the supplied Scopus record. Such indicators can help contextualize research influence, while citation practices vary among disciplines. A balanced assessment should also consider clinical relevance, reproducibility, methodological rigor, collaboration, and evidence of use beyond citation counts.[1][3]
Award Suitability
The Innovative Research Award is potentially aligned with an epidemiology researcher when documented work demonstrates originality, methodological advancement, meaningful evidence generation, or practical relevance. Muzaffer Sanci’s supplied publication and citation indicators provide contextual evidence of research activity, while final award suitability should depend on independently verified scholarly contributions and eligibility criteria for recognition.[5]
Conclusion
Muzaffer Sanci’s supplied academic record presents an established epidemiology-oriented research profile, with 165 documents, 1,526 citations, and an h-index of 21. These metrics support recognition of sustained scholarly activity, but they should be considered with qualitative evidence. The Innovative Research Award assessment should therefore combine bibliometric information with verified research contributions and documented scientific relevance.[4]
External Links
References
- Elsevier. (n.d.). Scopus author details: Muzaffer Sanci, Author ID 6508123738. Scopus.
https://www.scopus.com/pages/authors/6508123738
- Özuyar Şimşek, G., Uzunlar, Ö., Özen, S., Çandar, T., Sancı, M., & Duman, E. D. (2026). Investigation of the effect of TNF-α levels on infertility duration and infertility characteristics in endometriosis patients presenting with infertility complaints. BMC Women’s Health, 26(1).
https://doi.org/10.1186/s12905-026-04586-w
- Özen, S., Güner Özen, E., Özuyar Şimşek, G., Arzik, A. O., Karaoğlu, S., Akdemir, C., & Sanci, M. (2026). HPV persistence and CIN2+ detection in women with normal cytology and non-16/18 high-risk HPV positivity. BMC Women’s Health.
https://doi.org/10.1186/s12905-026-04278-5
- Korkmaz, O., Aydemir, I., Turkoz Uluer, E., Sancı, M., Diniz, G., Sayhan, S., & İnan, S. (2026). Stage-dependent expression and nuclear localization of EZH2 in endometrial carcinogenesis: Evidence from cell lines and human tissues. Journal of Molecular Histology, 57, Article 262.
https://doi.org/10.1007/s10735-026-10930-z
- Özen, S., Güner Özen, E., & Sancı, M. (2026). Preoperative imaging for nodal assessment in endometrial carcinoma: A comparative study of MRI and 18F-FDG PET/CT across risk groups. Medicina, 62(7), 1418.
https://doi.org/10.3390/medicina62071418